UB Paderborn / Katalog / Suche / in CDI

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Nature (London), 2020-02, Vol.578 (7793), p.160-165

2020

Volltextzugriff (PDF)

Interplay between Single Resistance-Associated Mutations in the HIV-1 Protease and Viral Infectivity, Protease Activity, and Inhibitor Sensitivity

Antimicrobial Agents and Chemotherapy, 2012-02, Vol.56 (2), p.623-633

2012

Volltextzugriff (PDF)

Virologic Failure in Therapy-Naïve Subjects on Aplaviroc plus Lopinavir-Ritonavir: Detection of Aplaviroc Resistance Requires Clonal Analysis of Envelope

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.1124-1131

2009

Volltextzugriff (PDF)

Virologic Failure in First-Line Human Immunodeficiency Virus Therapy with a CCR5 Entry Inhibitor, Aplaviroc, plus a Fixed-Dose Combination of Lamivudine-Zidovudine: Nucleoside Reverse Transcriptase Inhibitor Resistance Regardless of Envelope Tropism

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.1116-1123

2009

Volltextzugriff (PDF)

Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (12), p.2689-2694

2017

Volltextzugriff (PDF)

No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank

BMC research notes, 2014-08, Vol.7 (1), p.461-461, Article 461

2014

Volltextzugriff (PDF)

Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles

Journal of Virology, 2000-01, Vol.74 (1), p.371-378

2000

Volltextzugriff (PDF)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents

Journal of Virus Eradication, 2019-12, Vol.5, p.47-48

2019

Volltextzugriff (PDF)

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals

AIDS (London), 2008-07, Vol.22 (12), p.1425-1431

2008

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of Macrocyclized Betulin Derivatives as a Novel Class of Anti-HIV-1 Maturation Inhibitors

The open medicinal chemistry journal, 2014, Vol.8 (1), p.23-27

2014

Volltextzugriff (PDF)

Virologic Failure in Therapy-Naïve Subjects on Aplaviroc plus Lopinavir-Ritonavir: Detection of Aplaviroc Resistance Requires Clonal Analysis of Envelope

Antimicrobial agents and chemotherapy, 2009-03, Vol.53 (3), p.1124-1131

2009

Volltextzugriff (PDF)

Sensitivity of Phenotypic Susceptibility Analyses for Nonthymidine Nucleoside Analogues Conferred by K65R or M184V in Mixtures with Wild-Type HIV-1

The Journal of infectious diseases, 2009-01, Vol.199 (1), p.84-88

2009

Volltextzugriff (PDF)

Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector

Journal of Virology, 1997-04, Vol.71 (4), p.3031-3038

1997

Volltextzugriff (PDF)

Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles

Journal of virology, 2000-04, Vol.74 (7), p.3430-3430

2000

Volltextzugriff (PDF)

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo

The Journal of clinical investigation, 2022-04, Vol.132 (8), p.1-14

2022

Volltextzugriff (PDF)

Combined noncanonical NF-[kappa]B agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo

The Journal of clinical investigation, 2022-04, Vol.132 (8)

2022

Volltextzugriff (PDF)

Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine

Journal of acquired immune deficiency syndromes (1999), 2006-11, Vol.43 (3), p.284

2006

Volltextzugriff (PDF)

Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and Lamivudine can be successfully treated with a quadruple-nucleoside regimen

Journal of acquired immune deficiency syndromes (1999), 2006-01, Vol.41 (1), p.127

2006

Volltextzugriff (PDF)

Salvage Therapy With Abacavir and Other Reverse Transcriptase Inhibitors for Human Immunodeficiency-Associated Encephalopathy

The Pediatric infectious disease journal, 2006-12, Vol.25 (12), p.1142-1152

2006

Volltextzugriff (PDF)

Determination of vitamins D, A, and E in sera and vitamin D in milk from captive and free-ranging polar bears (Ursus maritimus), and 7-dehydrocholesterol levels in skin from captive polar bears

Zoo biology, 1998, Vol.17 (4), p.285-293

1998

Volltextzugriff (PDF)

The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance

AIDS research and human retroviruses, 1999-03, Vol.15 (4), p.355-363

1999

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Interplay between Single Resistance-Associated Mutations in the HIV-1 Protease and Viral Infectivity, Protease Activity, and Inhibitor Sensitivity

Virologic Failure in Therapy-Naïve Subjects on Aplaviroc plus Lopinavir-Ritonavir: Detection of Aplaviroc Resistance Requires Clonal Analysis of Envelope

Virologic Failure in First-Line Human Immunodeficiency Virus Therapy with a CCR5 Entry Inhibitor, Aplaviroc, plus a Fixed-Dose Combination of Lamivudine-Zidovudine: Nucleoside Reverse Transcriptase Inhibitor Resistance Regardless of Envelope Tropism

Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphisms

No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank

Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals

Synthesis and Biological Evaluation of Macrocyclized Betulin Derivatives as a Novel Class of Anti-HIV-1 Maturation Inhibitors

Virologic Failure in Therapy-Naïve Subjects on Aplaviroc plus Lopinavir-Ritonavir: Detection of Aplaviroc Resistance Requires Clonal Analysis of Envelope

Sensitivity of Phenotypic Susceptibility Analyses for Nonthymidine Nucleoside Analogues Conferred by K65R or M184V in Mixtures with Wild-Type HIV-1

Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector

Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo

Combined noncanonical NF-[kappa]B agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo

Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine

Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and Lamivudine can be successfully treated with a quadruple-nucleoside regimen

Salvage Therapy With Abacavir and Other Reverse Transcriptase Inhibitors for Human Immunodeficiency-Associated Encephalopathy

Determination of vitamins D, A, and E in sera and vitamin D in milk from captive and free-ranging polar bears (Ursus maritimus), and 7-dehydrocholesterol levels in skin from captive polar bears

The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance

Suchergebnisse filtern